Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Virax Biolabs Group stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VRAX.
You can purchase shares of Virax Biolabs Group (NASDAQ:VRAX) through any online brokerage.
Other companies in Virax Biolabs Group’s space includes: Akso Health (NASDAQ:AHG), McKesson (NYSE:MCK), Henry Schein (NASDAQ:HSIC), Cencora (NYSE:COR) and Agape ATP (NASDAQ:ATPC).
Virax Biolabs Group has a consensus price target of $3.00.
The stock price for Virax Biolabs Group (NASDAQ: VRAX) is $0.9999 last updated May 23, 2025 at 10:06 AM EDT.
There are no upcoming dividends for Virax Biolabs Group.
Virax Biolabs Group does not have any upcoming earnings scheduled.
There is no upcoming split for Virax Biolabs Group.
Virax Biolabs Group is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.